Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Rating) CEO Brian Mckelligon sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $5.71, for a total value of $28,550.00. Following the sale, the chief executive officer now directly owns 152,563 shares in the company, […]
Board of Trustees of The Leland Stanford Junior University decreased its stake in Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Rating) by 19.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 620,434 shares of the company’s stock after selling 153,682 […]
Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Rating) have received an average rating of “Buy” from the seven analysts that are presently covering the company, MarketBeat reports. Four analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have updated their coverage on the stock in the […]